Literature DB >> 29078267

Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood.

Sudhir K Yadav1, Sridhar Boppana1,2, Naoko Ito1, John E Mindur1,3, Martin T Mathay1,4, Ankoor Patel1, Suhayl Dhib-Jalbut1, Kouichi Ito5.   

Abstract

Multiple sclerosis (MS) is an autoimmune disease targeting the central nervous system (CNS) mainly in young adults, and a breakage of immune tolerance to CNS self-antigens has been suggested to initiate CNS autoimmunity. Age and microbial infection are well-known factors involved in the development of autoimmune diseases, including MS. Recent studies have suggested that alterations in the gut microbiota, referred to as dysbiosis, are associated with MS. However, it is still largely unknown how gut dysbiosis affects the onset and progression of CNS autoimmunity. In this study, we investigated the effects of age and gut dysbiosis on the development of CNS autoimmunity in humanized transgenic mice expressing the MS-associated MHC class II (MHC-II) gene, HLA-DR2a, and T-cell receptor (TCR) genes specific for MBP87-99/DR2a that were derived from an MS patient. We show here that the induction of gut dysbiosis triggers the development of spontaneous experimental autoimmune encephalomyelitis (EAE) during adolescence and early young adulthood, while an increase in immunological tolerance with aging suppresses disease onset after late young adulthood in mice. Furthermore, gut dysbiosis induces the expression of complement C3 and production of the anaphylatoxin C3a, and down-regulates the expression of the Foxp3 gene and anergy-related E3 ubiquitin ligase genes. Consequently, gut dysbiosis was able to trigger the development of encephalitogenic T cells and promote the induction of EAE during the age window of young adulthood. Published under the PNAS license.

Entities:  

Keywords:  aging; complement; dysbiosis; immune tolerance; multiple sclerosis

Mesh:

Substances:

Year:  2017        PMID: 29078267      PMCID: PMC5676872          DOI: 10.1073/pnas.1615715114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  85 in total

1.  A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function.

Authors:  Klarissa Hanja Stürner; Uwe Borgmeyer; Christian Schulze; Ole Pless; Roland Martin
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

2.  Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut.

Authors:  Angela M Morton; Esen Sefik; Rabi Upadhyay; Ralph Weissleder; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

3.  Human monocyte-derived dendritic cells are a source of several complement proteins.

Authors:  E S Reis; J A M Barbuto; L Isaac
Journal:  Inflamm Res       Date:  2006-05       Impact factor: 4.575

Review 4.  Role of puberty in multiple sclerosis risk and course.

Authors:  Tanuja Chitnis
Journal:  Clin Immunol       Date:  2013-04-02       Impact factor: 3.969

Review 5.  The epidemiology of autoimmune diseases.

Authors:  Glinda S Cooper; Berrit C Stroehla
Journal:  Autoimmun Rev       Date:  2003-05       Impact factor: 9.754

6.  Accumulation of immunoglobulin-containing cells in the gut mucosa and presence of faecal immunoglobulin in severe combined immunodeficient (scid) mice with T cell-induced inflammatory bowel disease (IBD).

Authors:  S Bregenholt; J Brimnes; J Reimann; M H Claesson
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

7.  The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis.

Authors:  T Bamba; H Matsuda; M Endo; Y Fujiyama
Journal:  J Gastroenterol       Date:  1995-11       Impact factor: 7.527

8.  Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon.

Authors:  Seong Gyu Jeon; Hisako Kayama; Yoshiyasu Ueda; Takuya Takahashi; Takashi Asahara; Hirokazu Tsuji; Noriko M Tsuji; Hiroshi Kiyono; Ji Su Ma; Takashi Kusu; Ryu Okumura; Hiromitsu Hara; Hiroki Yoshida; Masahiro Yamamoto; Koji Nomoto; Kiyoshi Takeda
Journal:  PLoS Pathog       Date:  2012-05-31       Impact factor: 6.823

9.  Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus.

Authors:  Deepshika Ramanan; Mei San Tang; Rowann Bowcutt; P'ng Loke; Ken Cadwell
Journal:  Immunity       Date:  2014-07-31       Impact factor: 31.745

10.  Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver.

Authors:  Mayuka Nakajima; Kei Arimatsu; Tamotsu Kato; Yumi Matsuda; Takayoshi Minagawa; Naoki Takahashi; Hiroshi Ohno; Kazuhisa Yamazaki
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

View more
  11 in total

Review 1.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Deciphering microbiome and neuroactive immune gene interactions in schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2018-11-22       Impact factor: 5.996

3.  Oral Delivery of Encapsulated All-Trans Retinoic Acid Ameliorates Disease in Rodent Models of Colitis.

Authors:  Ferdinando Nicoletti; Laura Hammer; Stacia Furtado; Katia Mangano; Edith Mathiowitz; Benjamin Green; Dominick L Auci
Journal:  Inflamm Bowel Dis       Date:  2022-03-02       Impact factor: 7.290

4.  ERAP1 deficient mice have reduced Type 1 regulatory T cells and develop skeletal and intestinal features of Ankylosing Spondylitis.

Authors:  Yuliya Pepelyayeva; David P W Rastall; Yasser A Aldhamen; Patrick O'Connell; Sandra Raehtz; Fadel S Alyaqoub; Maja K Blake; Ashley M Raedy; Ariana M Angarita; Abdulraouf M Abbas; Cristiane N Pereira-Hicks; Sarah G Roosa; Laura McCabe; Andrea Amalfitano
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

Review 5.  The microbiome and autoimmunity: a paradigm from the gut-liver axis.

Authors:  Bo Li; Carlo Selmi; Ruqi Tang; M E Gershwin; Xiong Ma
Journal:  Cell Mol Immunol       Date:  2018-04-30       Impact factor: 11.530

6.  A Gut Feeling: A Hypothesis of the Role of the Microbiome in Attention-Deficit/Hyperactivity Disorders.

Authors:  Xue Ming; Neil Chen; Carly Ray; Gretchen Brewer; Jeffrey Kornitzer; Robert A Steer
Journal:  Child Neurol Open       Date:  2018-07-11

Review 7.  Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored.

Authors:  Edit Mikó; Tünde Kovács; Éva Sebő; Judit Tóth; Tamás Csonka; Gyula Ujlaki; Adrienn Sipos; Judit Szabó; Gábor Méhes; Péter Bai
Journal:  Cells       Date:  2019-03-29       Impact factor: 6.600

8.  Oral neonatal antibiotic treatment perturbs gut microbiota and aggravates central nervous system autoimmunity in Dark Agouti rats.

Authors:  Suzana Stanisavljević; Aleksa Čepić; Svetlana Bojić; Katarina Veljović; Sanja Mihajlović; Neda Đedović; Bojan Jevtić; Miljana Momčilović; Milica Lazarević; Marija Mostarica Stojković; Đorđe Miljković; Nataša Golić
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

Review 9.  The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology.

Authors:  Maria Chiara Buscarinu; Arianna Fornasiero; Silvia Romano; Michela Ferraldeschi; Rosella Mechelli; Roberta Reniè; Emanuele Morena; Carmela Romano; Giulia Pellicciari; Anna Chiara Landi; Marco Salvetti; Giovanni Ristori
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

10.  Treating impulsivity with probiotics in adults (PROBIA): study protocol of a multicenter, double-blind, randomized, placebo-controlled trial.

Authors:  Gara Arteaga-Henríquez; Silvia Karina Rosales-Ortiz; Alejandro Arias-Vásquez; Istvan Bitter; Ylva Ginsberg; Pol Ibañez-Jimenez; Tünde Kilencz; Catharina Lavebratt; Silke Matura; Andreas Reif; Janos Rethelyi; Vanesa Richarte; Nanda Rommelse; Anne Siegl; J Antoni Ramos-Quiroga
Journal:  Trials       Date:  2020-02-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.